ARTICLE | Clinical News
NOxCF regulatory update
May 11, 2015 7:00 AM UTC
The European Commission granted Orphan Drug designation to AIT’s AIT-CF to treat cystic fibrosis (CF). The inhaled nitric oxide formulation using the company’s drug delivery system has completed a Ph...